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cation before they can be used to aggregate rates or effect sizes in
outcomes research, under the constraint of no common underlying
effect or rate. Methods: Studies are presented that require different
types of risk adjustment. First, we demonstrate using rates that
external risk adjustment through standardization can be achieved
using modiﬁed meta-analytic methods, but only with a model that
allows input of user-deﬁned weights. Next, we extend these observa-
tions to internal risk adjustment of comparative effect sizes. Results:
We show that this procedure produces identical results to conven-
tional age standardization if a rate is being standardized for age. We
also demonstrate that risk adjustment of effect sizes can be achievedee front matter Copyright & 2014, International S
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sbane, Australia.with this modiﬁed method but cannot be done using standard meta-
analysis. Conclusions: We conclude that this method allows risk
adjustment to be performed in situations in which currently the
ﬁxed- or random-effects methods of meta-analysis are inappropri-
ately used. The latter should be avoided when the underlying aim is
risk adjustment rather than meta-analysis.
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The term standardization refers to the process of facilitating
comparison of summary measures of burden or risk of disease
across populations. Such standardization can be done in two
ways. Internal standardization refers to the process of ensuring
that summary measures adequately reﬂect the distribution of
burden or risk of disease within subpopulations of the same
overall population. If the subpopulations are investigated inde-
pendently of each other (e.g., in separate studies), the overall
summary measure for the total population needs to take account
of the actual size of each subpopulation within the overall
population structure so that the overall summary reﬂects the
actual population meaningfully. For example, a summary meas-
ure of mortality reported in different subpopulations by age can
be combined into a summary measure for the total population
after standardizing against the actual distribution of ages. When
such standardized rates are compared across different popula-
tions, they can be interpreted as the mortality rate for an average
member of each speciﬁc population. Thus, mortality rates in
Australia versus India, obtained from different subpopulations,
need to be internally standardized against the actual population
structure in Australia and India, respectively, if a summary for
each country is to be compared.
External standardization can also be done by replacing the
internal standard described above with a common external
standard against which subpopulations from different popula-
tions are standardized, thus removing the subpopulation effectcompletely. This is of particular importance to studies of quality
improvement, in which many estimates of disease burden or risk
are strongly dependent on subpopulation, with rates of incidence
or mortality being much higher or lower between different
subpopulations. In this situation, the differences between pop-
ulations independent of the confounding by sizes of subpopula-
tions with different risks can be determined by standardizing
against a common external standard. In this sort of standardiza-
tion, the standardized rate is in itself useful only for comparison
and has no intrinsic interpretation.
The process of risk adjustment encompasses both standardiza-
tion and other procedures for accounting for the effects of
subpopulations with different risks. In this article, risk adjust-
ment and standardization will both refer to methods of adjust-
ment based on weighted averages in which the weights are
chosen to provide an “appropriate” basis for the comparison
(i.e., a “standard”). The latter is generally either the subpopula-
tion sizes from each of the populations in the comparison or from
a relevant external population. A common method in epidemi-
ology for this purpose has been direct standardization because it
can be applied on the basis of any subpopulation distribution, for
example, on the basis of age, geographical clusters, and cancer
incidence. Direct standardization is simply a process of weighted
averaging of the subpopulation-speciﬁc rates to arrive at a stand-
ardized estimate that reﬂects a given subpopulation structure.
The distribution of the “standard” provides the weights and
usually represents the current or most common subpopulation
structure for internal and external standardization, respectively,ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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graphic cluster or any other distribution of whatever standard is
to be applied. This provides, for each population, one risk-
adjusted or standardized rate that reﬂects the appropriate con-
tribution of the subpopulation-speciﬁc risk or rates to the stand-
ard. In this article, we demonstrate, using two examples, which
risk adjustment through direct standardization can be achieved
using modiﬁed meta-analytic methods, but only with our model
[1] that allows input of user-deﬁned weights. The advantage here
is that this method can now be extended to any standard and any
effect size (ES) other than rates.Methods
A modiﬁcation was undertaken of the quality-effects model [1] of
meta-analysis that allows moving the model from meta-analysis
to risk adjustment. This model uses a risk of bias weighting
scheme in addition to inverse variance weighting and the
modiﬁcation entailed removing inverse variance weights and
replacing bias weights with normalized subpopulation weights
from a standard population. The subpopulation weights are
applied using a modiﬁcation of our bias adjustment procedure
in meta-analysis [1,2] for each subpopulation to come up with a
weighted average that represents the single risk-adjusted or
standardized estimate across the subpopulations. This weighted
averaging procedure does not use inverse variance weights and
thus is not a meta-analysis. Therefore, if subpopulation rates are
being combined, it would give an equivalent result to direct
standardization used in epidemiology. We do not use log-
transformed rates because back transformation would result in
pooled estimates that depart from those computed using the
standard method. The standard method used for the computa-
tion of the directly standardized rate (DSR) is given by:
DSR¼ 1
∑
k
i¼1
Wj
 ∑
k
j¼1
wjoi
nj
ð1Þ
where Oj is the observed number of events in subpopulation (age
group) j, nj is the number of individuals in subpopulation (age
group) j (or the population  person-years at risk), and wj is the
weight based on the number/total (proportion) of individuals in
the age-group subpopulation j. The computations for the var-
iance and conﬁdence intervals of this DSR are outlined in Table 1.
However, this estimate can be derived by using a different
procedure. If weights are given by wαj ¼Qjþ τ^j (see Table 1 for the
computation of τ^j), Qj ¼ Nj=Nmax, Nj is the subpopulation size,
and ESj is the subpopulation effect estimate of interest, which
could be an ES, rate, or proportion, the directly standardized
effect estimate (DSE) is given by
DSE¼
∑ wαj  ESj
 
∑wαj
ð2Þ
In the computation of this DSE, rates can also be one of the
effect estimates standardized and in this special case, zero rates
are imputed to have variances based on a single observed event
as a continuity correction (see Table 1). The same method can be
used by substituting ESj for any other ES. For the odds ratios,
however, careful consideration should be given to whether the
marginal or the conditional odds ratios are of interest in a
particular analysis, given the mathematical fact that the mar-
ginal and conditional odds ratios are nonequivalent [3]. Two
examples are given below of the application of this procedure to
risk adjustment in outcomes research. In the ﬁrst example,
external risk adjustment is done via the new procedure and
compared with the direct method of age standardization todemonstrate equivalence. In the second example, this is then
extended to internal risk adjustment of a relative risk (RR)
measure using the incidence rates of cancer in each subpopu-
lation as the weights and demonstrates how this may be
extended beyond risk adjustment for rates.
A simulation was also run (for example 1) under sampling
variability by allowing [OjPoisson Oj
 
after replacing any Oj¼0
with 1. Thus, within each of the 18 age-group subpopulations, Oj
was now generated from a Poisson distribution with mean Oj. A
thousand iterations of each set of rates were run using Ersatz
version 1.3 (Epigear International Pty Ltd., Brisbane, Australia).
Coverage of the conﬁdence interval and percent bias was then
computed as described by Burton et al. [4].Results—Some Examples of Risk Adjustment
Example 1: External Risk Adjustment Across Age Groups and
a Simulation Study
Individual death records with multiple cause of death were the
primary source of data and accessed through the Australian
Bureau of Statistics for the period 1999 and 2006. Deaths were
coded according to the International Statistical Classiﬁcation
of Diseases, 10th Revision by using the automated Mortality Medical
Data System and results have been reported previously [5].
The Australian population age distribution in 2006 was used as
the external standard population for the purpose of risk adjust-
ment. To examine mortality trends and differentials across time,
we had created three estimates of a risk-adjusted mortality rate
from renal failure due to diabetes using standard methods
as follows [5]: 1) Risk-adjusted rates (underlying cause rate)
for diabetic renal disease based on deaths coded to diabetic
nephropathy; 2) Risk-adjusted rates (multiple cause rate 1) for
diabetic renal disease based on 1) above and additional deaths
coded to diabetes without complications but with renal failure
as a multiple cause; and 3) Risk-adjusted rates (multiple cause
rate 2) for diabetic renal disease based on 1) and 2) above
and additional deaths coded to diabetes with other complica-
tions (except nephropathy) but with renal failure as a
multiple cause.
The risk-adjusted cause-of-death rate of patients via our new
procedure is obtained as follows: 1) compute the cause rate of
each age subgroup of patients; 2) create a standardized weight
(Nj=Nmax) from the age composition of the external standard
population adopted as the 2006 population in our case; and 3)
apply the weighting procedure above to obtain the age-
standardized rate. Table 2 depicts the standard computation
versus the modiﬁed meta-analytic procedure results. The pooled
rates are identical because the process in both cases is weighted
averaging. The conﬁdence intervals differ marginally even
though the process for risk adjustment here is completely differ-
ent from the standard computation for direct standardization
of rates.
Results of the simulation are also shown in Table 2 and
demonstrate excellent coverage of the conﬁdence interval by this
method and reafﬁrm the appropriateness of the use of the
normal approximation to the Poisson distribution for the gen-
eration of the variance of the subpopulation rates even when
there are low event rates. Also, as expected with empirical
weights, the estimator is biased because of covariance between
the effect and the weights. This was demonstrated in the case of
rates, however, to be a very small percentage of the magnitude of
the effect and can therefore be ignored (Table 2).
Table 1 – Variance of the conventional directly
standardized rate (DSR) and of the new directly
standardized effect estimate (DSE).
DSR
The 100 (1–α)% conﬁdence limits for the directly standardised rate
(DSR) are given by*:
DSRlower ¼ DSRþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varðDSRÞ
varðOÞ
s
 OlowerOð Þ ð3Þ
DSRupper ¼ DSRþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varðDSRÞ
varðOÞ
s
 OupperO
 
ð4Þ
Using Byar's method [11], the 100 (1–α)% conﬁdence limits for the
observed number of events are given by†:
Olower ¼ O 1
1
9O
 z
3
ﬃﬃﬃﬃ
O
p
 3
ð5Þ
Oupper ¼ Oþ1ð Þ  1 19ðOþ1Þ þ
z
3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðOþ1Þ
p
 !3
ð6Þ
The variances of the observed count O and the DSR are estimated
by:
varðOjÞ ¼ ∑
k
j¼1
Oj ð7Þ
varðDSRÞ ¼ 1
∑kj¼1wj
 2  ∑k
j¼1
w2j Oj
n2j ð8Þ
DSE
The variance of this directly standardised estimate (DSE) is given
by‡:
varðDSEÞ¼∑ω2j
wαj
∑wαj
 !2
ð9Þ
The weight is given by wαj ¼ Qjþ τ^j as previously described [2] with
the modiﬁcation (compared to meta-analysis) that for the
purpose of generating the weights only, study variance is
assumed to be ¼ 1 for all j.
The computation of τ^j is as follows:
τ^j¼ ð∑τjÞk
Q 0j
∑Q 0j
" #
τj ð10Þ
where
Q 0j¼
τj∑Qj
ðk1Þ∑τj
h i
þQj if ð(ÞðQjÞQjo1
Qj otherwise
8<
: ð11Þ
and
τj¼
1Qj
k1 ð12Þ
* Where O is the total observed count of events in the local or
subject population; Olower and Oupper are the lower and upper
conﬁdence limits for the observed count of events; var(O) is the
variance of the total observed count O; var(DSR) is the variance of
the directly standardised rate.
† Where z is the 100 (1–α/2)th percentile value from the Standard
Normal distribution. For example, for a 95% conﬁdence interval, α
¼ 0.05 and z ¼ 1.96 (i.e. the 97.5th percentile value from the
standard normal distribution).
‡ Where ω2j ¼ s2j þγ2 where s2j is the sampling variability for the jth
category while γ2 is the method of moments estimate of between
category variance [12], this process representing a quasi-like-
lihood approach to overdispersion correction. For the speciﬁc
case of the rate, we can base the category speciﬁc sampling
variance on a normal approximation to the Poisson distribution,
s2j ¼ Oj  M=Pj
 2, in which Oj are the observed events, Pj is the
person-time of observation for the jth sub-population where
j ¼ 1,2,…,k and M is a constant multiplier (i.e. M ¼ 1000 if rates
are expressed per 1000). For all other effect sizes, the usual
variance formulation is used (after transformation if that is
required for normality).
Fig. 1 – Application of population weights in step two for
standardization of pooled individual cancer type RR estimates
in males. There were two estimates each for prostate, NHL
pancreatic, and hepatocellular cancer, and these were
combined via meta-analysis (before risk adjustment) to
arrive at the estimates in the ﬁgure. CI, conﬁdence interval;
CRC, colorectal cancer; NHL, non-Hodgkin's lymphoma; RR,
relative risk.
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Rates
We reanalyzed the report from various meta-analyses of risks of
different types of cancers in a recent article on cancer risk in
diabetes [6]. Subpopulation weights within the studies in this
article were the incidence ﬁgures in the United States of each
cancer type for the population (deﬁned by male sex). Where there
was more than one report of the same cancer type, a meta-
analysis was used to arrive at a single pooled estimate for that
cancer type. Next, population standardization by this modiﬁedTable 2 – Age-standardized death rates from renal
disease due to diabetes for Australia (1999 and
2006): Comparison of effects of calculating rates
using two different multiple cause–based deﬁni-
tions with those using an underlying cause only.
Age-standardized
death rates
(per 100,000)*
Australia
1999 2006
Underlying cause rate
(UCR)
0.671 (0.554–0.807) 0.636 (0.532–0.754)
Via the modiﬁed
procedure
0.671 (0.496–0.847) 0.636 (0.472–0.800)
Coverage of 95% CI 99.5% 99.5%
Bias% 5.2% 4.4%
Multiple cause rate 1
(MCR1)
2.494 (2.259–2.748) 3.436 (3.188–3.699)
Via the modiﬁed
procedure
2.494 (2.135–2.854) 3.436 (2.985–3.887)
Coverage of 95% CI 99.4% 99.9%
Bias% 1.3% 0.5%
Multiple cause rate 2
(MCR2)
3.171 (2.906–3.454) 4.256 (3.979–4.547)
Via the modiﬁed
procedure
3.171 (2.743–3.600) 4.256 (3.746–4.767)
Coverage of 95% CI 99.8% 99.9%
Bias% 0.8% 0.6%
CI, conﬁdence interval.
* Standardized to the Australian population in 2006.
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are averaging patient subpopulation RRs to arrive at a summary
RR for the whole population, it does not matter if all RRs come
from one study or from multiple studies (each providing a
subpopulation RR—as in this example). In addition, standard
subpopulation sizes are derived separately and need not be
derived from the same source. Thus, unlike a meta-analysis, in
which all studies are being pooled to achieve the best estimate of
an underlying reality, here, the standardized estimate is simply a
weighted mean event rate for a series of subpopulation RRs,
using the subpopulation sizes from the same population as the
weighting scheme.
Results are shown in Figure 1 and computed via the use of the
new procedure using an Excel sheet. It is evident that, for men,
the risks are lowest for prostate cancer and because this forms
the largest subpopulation by incidence (reﬂected by the size of
the boxes in Fig. 1), its ES dominates after risk adjustment.
Ignoring subpopulation weights would lead to the false impres-
sion that the overall cancer risk was increased, although in
reality, the overall cancer risk was not increased but rather the
smallest (lowest incidence) subpopulation groups (cancer types)
had increased risk. If this were to be compared with the
population of females (not shown), there would be a higher risk
in the female population because protective effects of diabetes
are not seen for any of the cancers in women.Discussion
The new procedure we outline for risk adjustment allows any ES
or rate or proportion of interest to be standardized against any
relevant subpopulation distribution. This would not have been
easy to do manually and that is why many studies of burden of
disease default to meta-analysis when risk adjustment is actually
being sought [7,8]. Up till now, there was no effective method of
introducing subpopulation weights into a meta-analytic proce-
dure and thus these researchers erroneously used conventional
models of meta-analysis when, in reality, risk adjustment was
required. This procedure differs from meta-analysis in that there
is no common underlying “true effect,” making inverse variance
weights redundant during the risk adjustment procedure—a
change that no longer allows us to call this procedure a meta-
analysis.
Assigning population weights to subpopulation ESs is a means
of correcting for disproportionate selection whether it is by age or
by geographic clustering. Thus, although a group of estimates, each
on its own, represents samples of its subpopulations, it may not be
representative on an entire population perspective. The process of
risk adjustment of rates is a classic epidemiological method that
removes the confounding effect of the subpopulation structure on
rates that differ in populations we wish to compare over time. It
also provides an easy-to-use whole population summary measure
that can be useful for decision makers. This is the most common
use of risk adjustment and is applied in two ways. First, rates of
disease across countries can be internally standardized to arrive at
an estimate of burden in the region. The second key role of this
procedure is in adjusting effect measures that reﬂect the quality of
health care among providers, for example, the use of externally risk-
adjusted death rates in determining hospital quality. Risk adjust-
ment is thus of importance in reconciling key differences among
patient subpopulations, thus permitting comparisons of like with
like. In both the latter instances, failure to adjust appropriately for
patient risk produces comparisons that are ﬂawed, misleading,
and, sometimes, meaningless.
Although standardization usually meant using a common
external standard, we have coined the term internal and external
standardization to distinguish the new category of standardizationwe term internal standardization. Burden of risk is the main target
of internal standardization or internal risk adjustment. The aim
here is to produce a valid comparison of whole population risk
from a risk factor that affects subpopulations differently. Thus, if
men and women are two different populations that contain
different sizes of the same cancer subpopulations, a comparison
of the effect of the risk factor (diabetes in our example) on overall
cancer risk requires risk adjustment based on cancer incidence.
The RR represents the RR of cancer with diabetes versus no
diabetes in each subpopulation, and the risk-adjusted RR tells us
what the overall burden of risk is on the basis of which cancers
are common or rare. We demonstrate that, overall, there is no net
increase in the burden of cancer risk in men because protective
effects are seen in some cancers. This is not so in women, so if
we were comparing the burden of risk from diabetes across
genders, the risk-adjusted RR gives the real difference—no net
change in men while a similar analysis in women (not shown)
would have demonstrated a net increase in cancer risk.
Some researchers have attempted to apply population
weights within meta-analysis [9] in an attempt at internal stand-
ardization of subgroup differences across the population. The
methodology used by the latter authors, however, does not seem
to be valid because they made the mistake of combining meta-
analysis and risk adjustment. We had previously advocated a
method for doing so [2], but this was incorrect [10], and as we
demonstrate here, this has to be done outside the framework of
meta-analysis per se. We demonstrate using the estimates for
cancer risk in diabetes how this should have been done (Fig. 1)
and results can sometimes be very different from what has
commonly been the case. Indeed, studies that have looked at
regional burden of disease may generate point estimates from
diverse populations using ﬁxed-effects models or random-effects
models [7,8] and this would obviously be wrong because the aim
here is risk adjustment as opposed to estimating the true under-
lying effect and thus the inverse variance weights or random-
effects weights based on study size have no real implication and
simply create bias.Conclusions
Both meta-analysis and risk adjustment share the common prop-
erty of weighted averaging. An ES may be adjusted for one or more
compositional characteristics of a population by treating ESs as
subgroups of a standard distribution with speciﬁc weights. These
weights are representative of the distribution of the characteristic
for which adjustment is desired. Following both the direct method
of risk adjustment and this modiﬁed meta-analytic procedure, the
adjusted ES is a weighted average of the subgroup ES that belongs
to either a hypothetical external standard or an internal standard
with distribution of subgroups as the weights. We advocate the use
of this modiﬁed meta-analytic procedure in these situations when
risk adjustment is sought. We also plan to introduce this procedure
as software that can assist researchers standardize across any ES
and any internal or external standard distribution (coming soon on
www.epigear.com).Acknowledgments
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